Multiple myeloma remains an incurable disease although the Ball - Nets prognosis has been improved by novel therapeutics and agents recently.Relapse occurs in the majority of patients and becomes fatal finally.Immunotherapy might be a powerful intervention to maintain a long-lasting control of minimal residual disease or to even eradicate disseminated tumor cells.
Several tumor-associated antigens have been identified in patients with multiple myeloma.These antigens are expressed in a tumor-specific or tumor-restricted pattern, In Ground Pool Kits are able to elicit immune response, and thus could serve as targets for immunotherapy.This review discusses immunogenic antigens with therapeutic potential for multiple myeloma.